Search

Filters

Clear Filters
3:00 PM - 3:10 PM ET

121 - Pirfenidone for Cancer Patients with Grade 2 and Grade 3 Radiation-Induced Lung Injury: Long-Term Efficacy and Exploratory Analysis from a Multicenter, Randomized Phase ll Clinical Trial
Speaker: Chen, Biqi, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong
8:30 AM - 8:35 AM ET

1210 - Modernizing the MD Anderson Stiefel Oropharynx Cancer Cohort Database through Development and Validation of Automated Data Extraction Algorithms
Speaker: Rinsurongkawong, Waree, PhD - MD Anderson Cancer Center, Houston, TX
8:05 AM - 8:10 AM ET

1211 - Contemporary Outcomes with Endoluminal High-Dose-Rate Brachytherapy for Esophageal Cancer
Speaker: Mondal, Janmenjoy, MD, MBA, MBBS - Medical College and Hospital Kolkata, Kolkata, West Benga
8:10 AM - 8:15 AM ET

1212 - Consolidation Chemotherapy after Definitive Concurrent Chemoradiotherapy in Patients with Locally Advanced, Inoperable Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Non-inferiority, Phase 3 Trial
Speaker: Fan, ChengCheng, MD - Affiliated Cancer Hospital of Zhengzhou university, Zhengzhou, HeNan
8:15 AM - 8:20 AM ET

1213 - Long-Term Survival and Biomarker-Based Exploratory Analysis of Nimotuzumab Combined with SIB-IMRT in Locally Advanced Esophageal Cancer: Insights from a Phase II Clinical Trial
Speaker: Zhao, Xiaohan, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
3:05 PM - 3:15 PM ET

1214 - Proton vs. Photon EBRT for Hepatocellular Carcinoma: A Multi-Institutional Individual Patient Data Analysis Using Propensity Score Weighting
Speaker: Yanagihara, Ted, MD, PhD - University of North Carolina, Chapel Hill, NC
8:20 AM - 8:25 AM ET

1215 - Long-Term Outcomes of Image-Guided Proton Therapy for Treatment-Naïve Solitary Hepatocellular Carcinoma Amenable to Surgical Resection or Radiofrequency Ablation: A Pooled Analysis of a Phase II Trial and Prospective Cohort
Speaker: Iwata, Hiromitsu, MD, PhD - Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya, Aichi
8:05 AM - 8:10 AM ET

1217 - Eugonadal Progression-Free Survival Following Intensification of Metastasis-Directed Stereotactic Body Radiotherapy with Radioligand Therapy or Androgen Annihilation Therapy: A Comparison of Two Phase II Trials
Speaker: Yu, Esther, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA
8:10 AM - 8:15 AM ET

1218 - Outcomes of Risk-Stratified and Intensified Salvage Re-Irradiation in Local Recurrence : A Prospective Cohort Comparison
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
8:15 AM - 8:20 AM ET

1219 - Stereotactic Prostate Cancer Ablative RE-Irradiation: A Systematic Review and Meta-Analysis (SPARE)
Speaker: Gouveia, Andre, MD, MBA - McMaster University, Hamilton, On
3:10 PM - 3:20 PM ET

122 - 64cu-Anti-CEA M5A PET Imaging Pre and Post Neoadjuvant Radiotherapy In Advanced Rectal Cancer
Speaker: Wong, Jeffrey, MD, FASTRO - City of Hope National Medical Center, Duarte, CA
8:20 AM - 8:25 AM ET

1220 - Salvage High-Dose-Rate Brachytherapy after Prior Prostate Radiotherapy: Contemporary Multi-Institutional Outcomes in 236 Patients
Speaker: Bilski, Mateusz, MD, PhD - Lublin Region Oncology Center, Lublin, lubelskie